In a mouse model of ovalbumin-induced asthma, administration of anti-IL-33 antibodies was shown to decrease eosinophil infiltration, IgE production, and Th2 cytokine release (34), as well as airway hyperreactivity (AHR) (35). This evidence concerns the gene IL33 and asthma.